Global Prostate Cancer Market Size, Share, Growth Trends, and Forecasts 2034
Prostate Cancer Market By Type (Localized Prostate Cancer, Locally Advanced Prostate Cancer, Metastatic Prostate Cancer, Castration Resistant Prostate Cancer), By Treatment (Surgery, Radiation Therapy, Hormone Therapy, Chemotherapy, Immunotherapy), By End-User (Hospitals, Cancer Treatment Centers, Diagnostic Centers, Ambulatory Surgical Centers), By Diagnosis (PSA Test, Biopsy, MRI Scan, Genetic Testing), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034
Category: Healthcare Report Format : PDF
Pages: 227 Report Code: ZMR-10751
Published Date: Aug-2026 Status : Published
| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 13.5 Billion | USD 29.9 Billion | 9.24% | 2025 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Prostate Cancer Market, (2026 - 2034) (USD Billion)
- 2.2 Global Prostate Cancer Market : snapshot
- Chapter 3. Global Prostate Cancer Market - Industry Analysis
- 3.1 Prostate Cancer Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The growing demand for minimally invasive and personalized treatment is driving the prostate cancer market.
- 3.3 Market Restraints
- 3.3.1. High treatment costs and limited screening access challenging the prostate cancer market
- 3.4 Market Opportunities
- 3.4.1. Expanding screening programs and emerging markets are driving growth opportunities in the prostate cancer market.
- 3.5 Market Challenges
- 3.5.1. The prostate cancer market face in sustaining growth and achieving widespread adoption
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Type
- 3.7.2 Market attractiveness analysis By Treatment
- 3.7.3 Market attractiveness analysis By End-User
- 3.7.4 Market attractiveness analysis By Diagnosis
- Chapter 4. Global Prostate Cancer Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Prostate Cancer Market: company market share, 2025
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Prostate Cancer Market - Type Analysis
- 5.1 Global Prostate Cancer Market overview: By Type
- 5.1.1 Global Prostate Cancer Market share, By Type, 2025 and 2034
- 5.2 Localized Prostate Cancer
- 5.2.1 Global Prostate Cancer Market by Localized Prostate Cancer, 2026 - 2034 (USD Billion)
- 5.3 Locally Advanced Prostate Cancer
- 5.3.1 Global Prostate Cancer Market by Locally Advanced Prostate Cancer, 2026 - 2034 (USD Billion)
- 5.4 Metastatic Prostate Cancer
- 5.4.1 Global Prostate Cancer Market by Metastatic Prostate Cancer, 2026 - 2034 (USD Billion)
- 5.5 Castration Resistant Prostate Cancer
- 5.5.1 Global Prostate Cancer Market by Castration Resistant Prostate Cancer, 2026 - 2034 (USD Billion)
- 5.1 Global Prostate Cancer Market overview: By Type
- Chapter 6. Global Prostate Cancer Market - Treatment Analysis
- 6.1 Global Prostate Cancer Market overview: By Treatment
- 6.1.1 Global Prostate Cancer Market share, By Treatment, 2025 and 2034
- 6.2 Surgery
- 6.2.1 Global Prostate Cancer Market by Surgery, 2026 - 2034 (USD Billion)
- 6.3 Radiation Therapy
- 6.3.1 Global Prostate Cancer Market by Radiation Therapy, 2026 - 2034 (USD Billion)
- 6.4 Hormone Therapy
- 6.4.1 Global Prostate Cancer Market by Hormone Therapy, 2026 - 2034 (USD Billion)
- 6.5 Chemotherapy
- 6.5.1 Global Prostate Cancer Market by Chemotherapy, 2026 - 2034 (USD Billion)
- 6.6 Immunotherapy
- 6.6.1 Global Prostate Cancer Market by Immunotherapy, 2026 - 2034 (USD Billion)
- 6.1 Global Prostate Cancer Market overview: By Treatment
- Chapter 7. Global Prostate Cancer Market - End-User Analysis
- 7.1 Global Prostate Cancer Market overview: By End-User
- 7.1.1 Global Prostate Cancer Market share, By End-User, 2025 and 2034
- 7.2 Hospitals
- 7.2.1 Global Prostate Cancer Market by Hospitals, 2026 - 2034 (USD Billion)
- 7.3 Cancer Treatment Centers
- 7.3.1 Global Prostate Cancer Market by Cancer Treatment Centers, 2026 - 2034 (USD Billion)
- 7.4 Diagnostic Centers
- 7.4.1 Global Prostate Cancer Market by Diagnostic Centers, 2026 - 2034 (USD Billion)
- 7.5 Ambulatory Surgical Centers
- 7.5.1 Global Prostate Cancer Market by Ambulatory Surgical Centers, 2026 - 2034 (USD Billion)
- 7.1 Global Prostate Cancer Market overview: By End-User
- Chapter 8. Global Prostate Cancer Market - Diagnosis Analysis
- 8.1 Global Prostate Cancer Market overview: By Diagnosis
- 8.1.1 Global Prostate Cancer Market share, By Diagnosis, 2025 and 2034
- 8.2 PSA Test
- 8.2.1 Global Prostate Cancer Market by PSA Test, 2026 - 2034 (USD Billion)
- 8.3 Biopsy
- 8.3.1 Global Prostate Cancer Market by Biopsy, 2026 - 2034 (USD Billion)
- 8.4 MRI Scan
- 8.4.1 Global Prostate Cancer Market by MRI Scan, 2026 - 2034 (USD Billion)
- 8.5 Genetic Testing
- 8.5.1 Global Prostate Cancer Market by Genetic Testing, 2026 - 2034 (USD Billion)
- 8.1 Global Prostate Cancer Market overview: By Diagnosis
- Chapter 9. Prostate Cancer Market - Regional Analysis
- 9.1 Global Prostate Cancer Market Regional Overview
- 9.2 Global Prostate Cancer Market Share, by Region, 2025 & 2034 (USD Billion)
- 9.3. North America
- 9.3.1 North America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.3.1.1 North America Prostate Cancer Market, by Country, 2026 - 2034 (USD Billion)
- 9.3.1 North America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4 North America Prostate Cancer Market, by Type, 2026 - 2034
- 9.4.1 North America Prostate Cancer Market, by Type, 2026 - 2034 (USD Billion)
- 9.5 North America Prostate Cancer Market, by Treatment, 2026 - 2034
- 9.5.1 North America Prostate Cancer Market, by Treatment, 2026 - 2034 (USD Billion)
- 9.6 North America Prostate Cancer Market, by End-User, 2026 - 2034
- 9.6.1 North America Prostate Cancer Market, by End-User, 2026 - 2034 (USD Billion)
- 9.7 North America Prostate Cancer Market, by Diagnosis, 2026 - 2034
- 9.7.1 North America Prostate Cancer Market, by Diagnosis, 2026 - 2034 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4.2.1 Europe Prostate Cancer Market, by Country, 2026 - 2034 (USD Billion)
- 9.4.2 Europe Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4 Europe Prostate Cancer Market, by Type, 2026 - 2034
- 9.4.1 Europe Prostate Cancer Market, by Type, 2026 - 2034 (USD Billion)
- 9.5 Europe Prostate Cancer Market, by Treatment, 2026 - 2034
- 9.5.1 Europe Prostate Cancer Market, by Treatment, 2026 - 2034 (USD Billion)
- 9.6 Europe Prostate Cancer Market, by End-User, 2026 - 2034
- 9.6.1 Europe Prostate Cancer Market, by End-User, 2026 - 2034 (USD Billion)
- 9.7 Europe Prostate Cancer Market, by Diagnosis, 2026 - 2034
- 9.7.1 Europe Prostate Cancer Market, by Diagnosis, 2026 - 2034 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.5.3.1 Asia Pacific Prostate Cancer Market, by Country, 2026 - 2034 (USD Billion)
- 9.5.3 Asia Pacific Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4 Asia Pacific Prostate Cancer Market, by Type, 2026 - 2034
- 9.4.1 Asia Pacific Prostate Cancer Market, by Type, 2026 - 2034 (USD Billion)
- 9.5 Asia Pacific Prostate Cancer Market, by Treatment, 2026 - 2034
- 9.5.1 Asia Pacific Prostate Cancer Market, by Treatment, 2026 - 2034 (USD Billion)
- 9.6 Asia Pacific Prostate Cancer Market, by End-User, 2026 - 2034
- 9.6.1 Asia Pacific Prostate Cancer Market, by End-User, 2026 - 2034 (USD Billion)
- 9.7 Asia Pacific Prostate Cancer Market, by Diagnosis, 2026 - 2034
- 9.7.1 Asia Pacific Prostate Cancer Market, by Diagnosis, 2026 - 2034 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.6.4.1 Latin America Prostate Cancer Market, by Country, 2026 - 2034 (USD Billion)
- 9.6.4 Latin America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4 Latin America Prostate Cancer Market, by Type, 2026 - 2034
- 9.4.1 Latin America Prostate Cancer Market, by Type, 2026 - 2034 (USD Billion)
- 9.5 Latin America Prostate Cancer Market, by Treatment, 2026 - 2034
- 9.5.1 Latin America Prostate Cancer Market, by Treatment, 2026 - 2034 (USD Billion)
- 9.6 Latin America Prostate Cancer Market, by End-User, 2026 - 2034
- 9.6.1 Latin America Prostate Cancer Market, by End-User, 2026 - 2034 (USD Billion)
- 9.7 Latin America Prostate Cancer Market, by Diagnosis, 2026 - 2034
- 9.7.1 Latin America Prostate Cancer Market, by Diagnosis, 2026 - 2034 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Prostate Cancer Market, by Country, 2026 - 2034 (USD Billion)
- 9.7.5 The Middle-East and Africa Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 9.4 The Middle-East and Africa Prostate Cancer Market, by Type, 2026 - 2034
- 9.4.1 The Middle-East and Africa Prostate Cancer Market, by Type, 2026 - 2034 (USD Billion)
- 9.5 The Middle-East and Africa Prostate Cancer Market, by Treatment, 2026 - 2034
- 9.5.1 The Middle-East and Africa Prostate Cancer Market, by Treatment, 2026 - 2034 (USD Billion)
- 9.6 The Middle-East and Africa Prostate Cancer Market, by End-User, 2026 - 2034
- 9.6.1 The Middle-East and Africa Prostate Cancer Market, by End-User, 2026 - 2034 (USD Billion)
- 9.7 The Middle-East and Africa Prostate Cancer Market, by Diagnosis, 2026 - 2034
- 9.7.1 The Middle-East and Africa Prostate Cancer Market, by Diagnosis, 2026 - 2034 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Pfizer
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 AstraZeneca
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Johnson and Johnson
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Bayer
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Astellas Pharma
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Sanofi
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Merck
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Novartis
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Bristol Myers Squibb
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Amgen
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 and others.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.1 Pfizer
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Prostate Cancer Market attractiveness, By Type
- 6. Global Prostate Cancer Market attractiveness, By Treatment
- 7. Global Prostate Cancer Market attractiveness, By End-User
- 8. Global Prostate Cancer Market attractiveness, By Diagnosis
- 9. Global Prostate Cancer Market share by Type, 2026 and 2034 (USD Billion)
- 10. Global Prostate Cancer Market by Localized Prostate Cancer, 2026 - 2034 (USD Billion)
- 11. Global Prostate Cancer Market by Locally Advanced Prostate Cancer, 2026 - 2034 (USD Billion)
- 12. Global Prostate Cancer Market by Metastatic Prostate Cancer, 2026 - 2034 (USD Billion)
- 13. Global Prostate Cancer Market by Castration Resistant Prostate Cancer, 2026 - 2034 (USD Billion)
- 14. Global Prostate Cancer Market share by Treatment, 2026 and 2034 (USD Billion)
- 15. Global Prostate Cancer Market by Surgery, 2026 - 2034 (USD Billion)
- 16. Global Prostate Cancer Market by Radiation Therapy, 2026 - 2034 (USD Billion)
- 17. Global Prostate Cancer Market by Hormone Therapy, 2026 - 2034 (USD Billion)
- 18. Global Prostate Cancer Market by Chemotherapy, 2026 - 2034 (USD Billion)
- 19. Global Prostate Cancer Market by Immunotherapy, 2026 - 2034 (USD Billion)
- 20. Global Prostate Cancer Market share by End-User, 2026 and 2034 (USD Billion)
- 21. Global Prostate Cancer Market by Hospitals, 2026 - 2034 (USD Billion)
- 22. Global Prostate Cancer Market by Cancer Treatment Centers, 2026 - 2034 (USD Billion)
- 23. Global Prostate Cancer Market by Diagnostic Centers, 2026 - 2034 (USD Billion)
- 24. Global Prostate Cancer Market by Ambulatory Surgical Centers, 2026 - 2034 (USD Billion)
- 25. Global Prostate Cancer Market share by Diagnosis, 2026 and 2034 (USD Billion)
- 26. Global Prostate Cancer Market by PSA Test, 2026 - 2034 (USD Billion)
- 27. Global Prostate Cancer Market by Biopsy, 2026 - 2034 (USD Billion)
- 28. Global Prostate Cancer Market by MRI Scan, 2026 - 2034 (USD Billion)
- 29. Global Prostate Cancer Market by Genetic Testing, 2026 - 2034 (USD Billion)
- 30. Global Prostate Cancer Market share, by Region, 2026 and 2034
- 31. North America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 32. Europe Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 33. Asia Pacific Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 34. Latin America Prostate Cancer Market, 2026 - 2034 (USD Billion)
- 35. The Middle-East and Africa Prostate Cancer Market, 2026 - 2034 (USD Billion)
Table Of Tables
- 1. Global Prostate Cancer Market: Snapshot
- 2. Drivers of the Prostate Cancer Market: impact analysis
- 3. North America Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 4. North America Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 5. North America Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 6. North America Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 7. U.S. Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 8. U.S. Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 9. U.S. Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 10. U.S. Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 11. Canada Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 12. Canada Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 13. Canada Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 14. Canada Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 15. Europe Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 16. Europe Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 17. Europe Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 18. Europe Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 19. Germany Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 20. Germany Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 21. Germany Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 22. Germany Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 23. France Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 24. France Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 25. France Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 26. France Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 27. U.K. Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 28. U.K. Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 29. U.K. Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 30. U.K. Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 31. Italy Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 32. Italy Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 33. Italy Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 34. Italy Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 35. Spain Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 36. Spain Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 37. Spain Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 38. Spain Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 39. Rest of Europe Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 40. Rest of Europe Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 41. Rest of Europe Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 42. Rest of Europe Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 43. Asia Pacific Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 44. Asia Pacific Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 45. Asia Pacific Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 46. Asia Pacific Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 47. China Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 48. China Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 49. China Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 50. China Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 51. Japan Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 52. Japan Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 53. Japan Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 54. Japan Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 55. India Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 56. India Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 57. India Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 58. India Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 59. South Korea Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 60. South Korea Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 61. South Korea Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 62. South Korea Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 63. South-East Asia Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 64. South-East Asia Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 65. South-East Asia Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 66. South-East Asia Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 67. Rest of Asia Pacific Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 68. Rest of Asia Pacific Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 69. Rest of Asia Pacific Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 70. Rest of Asia Pacific Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 71. Latin America Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 72. Latin America Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 73. Latin America Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 74. Latin America Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 75. Brazil Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 76. Brazil Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 77. Brazil Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 78. Brazil Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 79. Mexico Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 80. Mexico Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 81. Mexico Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 82. Mexico Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 83. Rest of Latin America Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 84. Rest of Latin America Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 85. Rest of Latin America Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 86. Rest of Latin America Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 87. The Middle-East and Africa Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 88. The Middle-East and Africa Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 89. The Middle-East and Africa Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 90. The Middle-East and Africa Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 91. GCC Countries Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 92. GCC Countries Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 93. GCC Countries Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 94. GCC Countries Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 95. South Africa Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 96. South Africa Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 97. South Africa Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 98. South Africa Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
- 99. Rest of Middle-East Africa Prostate Cancer Market revenue, By Type, 2026 - 2034 (USD Billion)
- 100. Rest of Middle-East Africa Prostate Cancer Market revenue, By Treatment, 2026 - 2034 (USD Billion)
- 101. Rest of Middle-East Africa Prostate Cancer Market revenue, By End-User, 2026 - 2034 (USD Billion)
- 102. Rest of Middle-East Africa Prostate Cancer Market revenue, By Diagnosis, 2026 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Prostate cancer is a type of cancer that develops in the prostate gland, a small organ in men that produces fluid needed for semen. It is one of the most common cancers among men and often grows slowly, although some cases can spread quickly if not detected and treated early.
The global prostate cancer market is expected to grow due to rising awareness about early screening, increasing incidence of prostate cancer in aging populations, growing demand for personalized treatment, and expanding research into new therapy options worldwide.
According to research, the global prostate cancer market was valued at approximately USD 13.5 billion in 2026 and is projected to reach approximately USD 29.9 billion by 2034.
The compound annual growth rate of the prostate cancer market is expected to be approximately 9.24% from 2026 to 2034.
North America is expected to lead the global prostate cancer market throughout the forecast period, driven by its strong healthcare research base, advanced screening infrastructure, and significant investment in cancer treatment innovation.
The major players in the global prostate cancer market include Pfizer, AstraZeneca, Johnson and Johnson, Bayer, Astellas Pharma, Sanofi, Merck, Novartis, Bristol Myers Squibb, and Amgen.
The report examines key aspects of the prostate cancer market, including research and development drivers, adoption barriers, treatment opportunities, competitive landscape dynamics, detailed regional market performance analysis, and a comprehensive forward-looking outlook across all major types, treatments, end-user segments, diagnostic methods, and geographic regions through 2034.
The prostate cancer market will benefit from rising healthcare spending, aging populations, and greater investment in cancer research. However, inflation, higher treatment costs, and pressure on healthcare budgets may slow the adoption of expensive therapies, especially in developing countries.
The prostate cancer market is seeing premium pricing for innovative targeted therapies and immunotherapies, while generic medicines and biosimilars are improving affordability. Governments and healthcare providers are also focusing on value-based pricing and cost-effective treatment to expand patient access.
The prostate cancer market is shifting toward early screening, personalized medicine, and minimally invasive treatments. Patients and healthcare providers increasingly prefer therapies that improve survival, reduce side effects, and support better quality of life through more precise and targeted treatment options.
HappyClients
